Related Experiment Video

Updated: Aug 15, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

A review of juvenile polyposis syndrome

Elizabeth Chow1, Finlay Macrae

  • 1Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Victoria, Australia. Elizabeth.Chow@mh.org.au

Journal of Gastroenterology and Hepatology
|October 26, 2005
PubMed

Insights

Juvenile Polyposis Syndrome, a rare disorder with cancer risk, is linked to SMAD4 and BMPR1A gene mutations. Understanding these genetic links aids in managing patients and their families.

Area of Science:

  • Genetics
  • Gastroenterology
  • Oncology

Background:

  • Juvenile Polyposis Syndrome (JPS) is a rare hamartomatous disorder.
  • JPS is associated with a significant risk of gastrointestinal cancer.
  • Recent discoveries link JPS to mutations in SMAD4 and BMPR1A genes.

Purpose of the Study:

  • To review current knowledge on JPS genetics and clinicopathological features.
  • To discuss expert recommendations for genetic testing and management.
  • To highlight the importance of the Transforming Growth Factor beta pathway in JPS.

Main Methods:

  • Literature review of JPS genetics.
  • Analysis of clinicopathological features.
  • Summary of current expert recommendations for management.

Main Results:

  • Mutations in SMAD4 and BMPR1A are key genetic factors in JPS.
  • These mutations are involved in the Transforming Growth Factor beta pathway.
  • Genetic findings are crucial for patient management and family screening.

Conclusions:

  • Understanding JPS genetics, particularly SMAD4 and BMPR1A mutations, is vital.
  • Genetic testing and tailored screening protocols improve patient outcomes.
  • Management strategies should incorporate genetic information for at-risk families.

More Related Videos

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...